These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20220121)

  • 1. The neglected brain in myotonic dystrophy types 1 and 2.
    van Engelen BG; de Leeuw FE
    Neurology; 2010 Apr; 74(14):1090-1. PubMed ID: 20220121
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
    Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
    Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND; Kraft E; Stüve O
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the ageing mind: a view from cognitive neuroscience.
    Hedden T; Gabrieli JD
    Nat Rev Neurosci; 2004 Feb; 5(2):87-96. PubMed ID: 14735112
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses.
    Bajrami A; Azman F; Yayla V; Cagirici S; Keskinkiliç C; Sozer N
    Neuroradiol J; 2017 Feb; 30(1):23-27. PubMed ID: 27837184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2.
    Kornblum C; Reul J; Kress W; Grothe C; Amanatidis N; Klockgether T; Schröder R
    J Neurol; 2004 Jun; 251(6):710-4. PubMed ID: 15311347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukoaraiosis: from an ancient term to an actual marker of poor prognosis.
    Pantoni L
    Stroke; 2008 May; 39(5):1401-3. PubMed ID: 18340098
    [No Abstract]   [Full Text] [Related]  

  • 9. Progression of cerebral white matter lesions -- clinical and radiological considerations.
    Enzinger C; Fazekas F; Ropele S; Schmidt R
    J Neurol Sci; 2007 Jun; 257(1-2):5-10. PubMed ID: 17321549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brain mapping under increasing cognitive complexity using regional cerebral blood flow measurements and positron emission tomography.
    Law I
    Dan Med Bull; 2007 Nov; 54(4):289-305. PubMed ID: 18208679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocephalus and cognitive decline in myotonic dystrophy: case report and literature review.
    Moroz A; Kalva S
    Arch Phys Med Rehabil; 1998 Aug; 79(8):1022-3. PubMed ID: 9710180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin skin: the cortical signature of prodromal AD?
    Rottenberg DA
    Neurology; 2009 Mar; 72(12):1038-9. PubMed ID: 19109535
    [No Abstract]   [Full Text] [Related]  

  • 13. Workshop Report: consensus on biomarkers of cerebral involvement in myotonic dystrophy, 2-3 December 2014, Milan, Italy.
    Bosco G; Diamanti S; Meola G;
    Neuromuscul Disord; 2015 Oct; 25(10):813-23. PubMed ID: 26341263
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.
    Klunk WE
    Arch Neurol; 2008 Oct; 65(10):1281-3. PubMed ID: 18852340
    [No Abstract]   [Full Text] [Related]  

  • 15. Teaching NeuroImages: FDG-PET in progressive supranuclear palsy.
    Renard D; Collombier L; Castelnovo G; Labauge P
    Neurology; 2010 Apr; 74(14):e60. PubMed ID: 20368626
    [No Abstract]   [Full Text] [Related]  

  • 16. Eyes and hands oscillation in HIV-associated neurocognitive disorder: A case report.
    Sugimoto A; Yazawa S; Nakao K; Ochiai E; Suzuki Y; Iwao K; Okayama A; Ohi T; Tsuruta K
    J Neurol Sci; 2019 Sep; 404():112-114. PubMed ID: 31362160
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of cognitive deficit by cardiac pacing in a young man with dystrophia myotonica.
    Roche SW; Schwarz A; Lane RJ; Bridges LR
    J R Soc Med; 1991 Oct; 84(10):625-6. PubMed ID: 1744853
    [No Abstract]   [Full Text] [Related]  

  • 18. Illuminating CNS and cognitive issues in myotonic dystrophy: Workshop report.
    Axford MM; Pearson CE
    Neuromuscul Disord; 2013 Apr; 23(4):370-4. PubMed ID: 23453858
    [No Abstract]   [Full Text] [Related]  

  • 19. How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1.
    Serra L; Petrucci A; Spanò B; Torso M; Olivito G; Lispi L; Costanzi-Porrini S; Giulietti G; Koch G; Giacanelli M; Caltagirone C; Cercignani M; Bozzali M
    Funct Neurol; 2015; 30(1):21-31. PubMed ID: 26214024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial emotion recognition and cerebral white matter lesions in myotonic dystrophy type 1.
    Kobayakawa M; Tsuruya N; Takeda A; Suzuki A; Kawamura M
    J Neurol Sci; 2010 Mar; 290(1-2):48-51. PubMed ID: 20006353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.